Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures?
Biological medicines contain a biological substance that is produced by or derived from a living organism. The active substances of biologicals are usually larger and more complex than those of chemically derived medicines (non-biological medicine). Biologicals are used for the treatment of chronic...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Revisão |
| Sprog: | engelsk |
| Udgivet: |
2013
|
| Online adgang: | https://doi.org/10.1007/s10198-013-0538-4 https://link.springer.com/content/pdf/10.1007/s10198-013-0538-4.pdf |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|